Cegła Paulina, Burchardt Ewa, Cholewiński Witold, Gwóźdź Sebastian, Roszak Andrzej, Kubiak Anna, Kaczmarek Aleksandra, Czepczyński Rafał
Department of Nuclear Medicine, Greater Poland Cancer Centre, Poznan, Poland.
Department of Radiotherapy and Oncological Gynaecology, Greater Poland Cancer Centre, Poznan, Poland.
Nuklearmedizin. 2020 Jun;59(3):241-247. doi: 10.1055/a-1084-4766. Epub 2020 Feb 25.
The aim of the study was to compare semiquantitative metabolic parameters of primary tumor assessed in vivo in F-FDG- and F-FLT in cervical cancer patients.
MATERIAL & METHODS: 39 patients with histologically confirmed cervical cancer underwent PET/CT scans acquired on separate days 60 min after i. v. injection of 364 ± 75 MBq of F-FDG and 259 ± 40 MBq of F-FLT. The reconstructed PET images were evaluated using a dedicated workstation for primary tumor semiquantitative parameters: SUV, MTV, TLG (for F-FLT-TLP) and heterogeneity (AUC-CSH). Wilcoxon-Mann-Whitney test and ROC curves were used for statistical analysis. Based on data from the local cancer registry and 3y- to -5y follow up patients were divided into 2 groups with regard to prognosis. Also differences between histopathological type and FIGO classification in two tracers were assessed.
Depending on PET/CT results, patients were divided into 3 groups: group 1 with disease limited only to the cervix, group 2 with disease limited to the cervix and iliac lymph nodes, and group 3 with disseminated disease. Statistically significant differences were found between keratinizing and non-keratinizing SCC in SUV (p = 0.03) and AUC-CSH (p = 0.04) only in F-FLT-PET/CT. Following cut-off values for nodal involvement in SUV, MTV, TLG/TLP and AUC-CSH were calculated using ROC curves: 13.5, 39.22, 255.94, 0.59 respectively for F-FDG and 12.1, 37.59, 140.01, 0.46 respectively for F-FLT. Higher values in both tracers in MTV and TLG/TLP were found in a group with worse prognosis.
This preliminary study suggests that higher values in MTV and TLG/TLP in both tracers might be associated with worse outcome in cervical cancer patients.